Hypertension in Pregnancy

Papers
(The median citation count of Hypertension in Pregnancy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial37
Genome-wide association study reveals HSF2, GJA1 and TRIM36 as susceptibility genes for preeclampsia: a community-based population study in Tianjin, China29
Effects of hypertensive disorders of pregnancy on the complications in very low birth weight neonates18
Administration of corticosteroid therapy for HELLP syndrome in pregnant women: evidences from seven randomized controlled trials16
Identification risk factors for perinatal complications among pregnant women with pulmonary arterial hypertension16
Blood pressure medication use and postpartum hospital readmission among preeclampsia patients14
Expression of Concern: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk12
Correction12
Pre-eclampsia screening with maternal risk factors and ophthalmic Doppler artery: a systematic review11
Statement of Retraction: Carbetocin versus oxytocin for prevention of postpartum hemorrhage in hypertensive women undergoing elective cesarean section11
WGCNA combined with machine learning for analysis of diagnostic markers of preeclampsia associated with the hedgehog signaling pathway11
First-trimester maternal renin-angiotensin-aldosterone system activation and the association with maternal telomere length after natural and IVF/ICSI conceived pregnancies: the Rotterdam periconceptio8
Short stature in small-for-gestational-age offspring born to mothers with hypertensive disorders of pregnancy8
Targeting oxidative stress in preeclampsia8
Umbilical cord-derived exosomal miR−548 is involved in driving preeclampsia pathogenesis by Inhibiting trophoblast cells invasion7
The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis5
Use of the USCOM® noninvasive cardiac output measurement system to predict the development of pre-eclampsia in hypertensive pregnancies5
Trimester and severity of SARS-CoV-2 infection during pregnancy and risk of hypertensive disorders in pregnancy5
Bioelectrical impedance–derived extracellular fluid expansion and perinatal outcomes in preeclampsia5
The role of early second trimester maternal serum cadherin-11 levels in the prediction of preeclampsia5
A nomogram for preeclampsia risk prediction in the first trimester: a nested case-control study5
Examining the relationship between maternal preeclampsia and autism spectrum disorder in childhood4
Distinguishing preeclampsia using the falling scaled slope (FSS) --- a novel photoplethysmographic morphological parameter4
SII serves as an independent diagnostic indicator for GDM and is regulated by placental 5-HT/NF-κB signaling4
Causal associations of metabolic dysfunction-associated steatotic liver disease with gestational hypertension and preeclampsia: a two-sample Mendelian randomization study4
Association of systemic inflammatory response index with severity of preeclampsia3
Endoplasmic reticulum stress-related genes drive M1 macrophage polarization in preeclampsia via modulating metabolic reprogramming: a bioinformatic study3
Cardiorespiratory fitness in women after severe pre-eclampsia3
Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?3
Magnesium sulfate improves blood flow of uterine, umbilical, and fetal middle cerebral arteries in women with severe preeclampsia at 30-34 gestational weeks3
Urine and serum L-type fatty acid-binding protein levels in preeclampsia: a prospective cohort study on maternal deterioration prediction3
Impact of behavioral phenotypes on response to a digital intervention to improve physical activity among postpartum individuals with hypertensive disorders of pregnancy3
The obesity associated FTO gene polymorphism and the risk of preeclampsia in Iranian women: A case–control study3
Maternal and neonatal outcome among women with early-onset preeclampsia and late-onset preeclampsia3
Soluble urinary somatic angiotensin converting enzyme is overexpressed in patients with preeclampsia: a potential new marker for the disease?3
Relationship between the hemodynamic profile and resistant hypertension in pregnant patients with hypertensive crisis3
Novel molecular strategies for preeclampsia management: a pathophysiological and therapeutic perspective2
Associations between extreme temperature exposure and hypertensive disorders in pregnancy: a systematic review and meta-analysis2
Elevated serum sFlt-1 at 18–20 weeks in advanced maternal age: a key difference from younger pregnancies2
Expression of NEDD4L and ENaC in Urinary Extracellular Vesicles in Pre-eclampsia2
Predicting intensive care need in women with preeclampsia using machine learning – a pilot study2
Integrated bioinformatics analysis identifies neutrophils and villous cytotrophoblasts infiltration characterized by BLC6 upregulation as associated with the co-occurrence of gestational diabetes mell2
Evaluation of a lifestyle intervention for women with gestational diabetes mellitus based on the medical internet of things: a randomized controlled trial with mid-sample verification2
Differences in hematocrit-to-plasma albumin ratio as a predictor of severe maternal morbidity in hypertensive disorders of pregnancy: a retrospective cohort study2
Hypertensive disorders of pregnancy after multifetal pregnancy reduction: a systematic review and meta-analysis2
Long-term outcomes of patients with preeclampsia, a review of the literature2
Expression of Concern: Maternal and fetal outcome in women with gestational hypertension in comparison to gestational proteinuria: A 3-year observational study2
KAT2A promotes NLRP3-mediated trophoblast pyroptosis in preeclampsia by the succinylation2
0.20197892189026